Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-12-063586
Filing Date
2012-11-16
Accepted
2012-11-16 17:27:38
Documents
9
Period of Report
2012-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v326124_10q.htm 10-Q 480923
2 EXHIBIT 31.1 v326124_ex31-1.htm EX-31.1 6472
3 EXHIBIT 32.1 v326124_ex32-1.htm EX-32.1 3329
  Complete submission text file 0001144204-12-063586.txt   4444921

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT xtls-20120930.xml EX-101.INS 477187
5 XBRL TAXONOMY EXTENSION SCHEMA xtls-20120930.xsd EX-101.SCH 41973
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE xtls-20120930_cal.xml EX-101.CAL 51009
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE xtls-20120930_def.xml EX-101.DEF 225378
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE xtls-20120930_lab.xml EX-101.LAB 391395
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE xtls-20120930_pre.xml EX-101.PRE 285477
Mailing Address 630 FIFTH AVENUE SUITE 2260 NEW YORK NY 10020
Business Address 630 FIFTH AVENUE SUITE 2600 NEW YORK NY 10020 201-934-2000
Xstelos Holdings, Inc. (Filer) CIK: 0001540145 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE
Type: 10-Q | Act: 34 | File No.: 000-54646 | Film No.: 121212682
SIC: 2834 Pharmaceutical Preparations